List of Excipients in API rosiglitazone maleate and metformin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing rosiglitazone maleate and metformin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Physicians Total Care Inc | AVANDAMET | rosiglitazone maleate and metformin hydrochloride | 54868-4965 | CELLULOSE, MICROCRYSTALLINE | |
| Physicians Total Care Inc | AVANDAMET | rosiglitazone maleate and metformin hydrochloride | 54868-4965 | FERRIC OXIDE RED | |
| Physicians Total Care Inc | AVANDAMET | rosiglitazone maleate and metformin hydrochloride | 54868-4965 | FERRIC OXIDE YELLOW | |
| Physicians Total Care Inc | AVANDAMET | rosiglitazone maleate and metformin hydrochloride | 54868-4965 | HYPROMELLOSE 2910 | |
| Physicians Total Care Inc | AVANDAMET | rosiglitazone maleate and metformin hydrochloride | 54868-4965 | LACTOSE MONOHYDRATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for rosiglitazone maleate and metformin hydrochloride
Excipient focus: CELLULOSE, MICROCRYSTALLINE
rosiglitazone maleate and metformin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
rosiglitazone maleate and metformin hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
rosiglitazone maleate and metformin hydrochloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
rosiglitazone maleate and metformin hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
rosiglitazone maleate and metformin hydrochloride drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
rosiglitazone maleate and metformin hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
rosiglitazone maleate and metformin hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K29/32
rosiglitazone maleate and metformin hydrochloride drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
rosiglitazone maleate and metformin hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
rosiglitazone maleate and metformin hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | rosiglitazone maleate and metformin hydrochloride | 54868-4965 |
| >Company | >Ingredient | >NDC |
rosiglitazone maleate and metformin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch